194 related articles for article (PubMed ID: 19064569)
1. Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma.
Schouten LJ; van Dijk BA; Oosterwijk E; van Engeland M; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Kester A; de Vogel S; Schalken JA; van den Brandt PA
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3543-50. PubMed ID: 19064569
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
[TBL] [Abstract][Full Text] [Related]
3. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.
Schouten LJ; van Dijk BA; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
J Hypertens; 2005 Nov; 23(11):1997-2004. PubMed ID: 16208141
[TBL] [Abstract][Full Text] [Related]
4. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
[TBL] [Abstract][Full Text] [Related]
5. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
Moore LE; Nickerson ML; Brennan P; Toro JR; Jaeger E; Rinsky J; Han SS; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Schmidt LS; Lenz P; Karami S; Linehan WM; Merino M; Chanock S; Boffetta P; Chow WH; Waldman FM; Rothman N
PLoS Genet; 2011 Oct; 7(10):e1002312. PubMed ID: 22022277
[TBL] [Abstract][Full Text] [Related]
6. von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry.
Lian F; Sreedharan S; Arnold RS; Master VA; Ogan K; Pattaras JG; Roberts DL; Petros JA
J Urol; 2014 Nov; 192(5):1528-33. PubMed ID: 24704013
[TBL] [Abstract][Full Text] [Related]
7. Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer.
van de Pol JAA; van den Brandt PA; van Engeland M; Godschalk RWL; van Schooten FJ; Hogervorst JGF; Schouten LJ
Sci Rep; 2020 Jan; 10(1):137. PubMed ID: 31924838
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.
Banks RE; Tirukonda P; Taylor C; Hornigold N; Astuti D; Cohen D; Maher ER; Stanley AJ; Harnden P; Joyce A; Knowles M; Selby PJ
Cancer Res; 2006 Feb; 66(4):2000-11. PubMed ID: 16488999
[TBL] [Abstract][Full Text] [Related]
9. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
10. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer.
Smits KM; Schouten LJ; Hudak E; Verhage B; van Dijk BA; Hulsbergen-van de Kaa CA; Goldbohm RA; Oosterwijk E; van den Brandt PA
Ann Epidemiol; 2010 May; 20(5):401-4. PubMed ID: 20382342
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis.
Inoue H; Nonomura N; Kojima Y; Shiba M; Oka D; Arai Y; Nakayama M; Takayama H; Nishimura K; Mori H; Okuyama A
Nephrol Dial Transplant; 2007 Jul; 22(7):2052-5. PubMed ID: 17438007
[TBL] [Abstract][Full Text] [Related]
13. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
Nickerson ML; Jaeger E; Shi Y; Durocher JA; Mahurkar S; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Mukeria A; Holcatova I; Schmidt LS; Toro JR; Karami S; Hung R; Gerard GF; Linehan WM; Merino M; Zbar B; Boffetta P; Brennan P; Rothman N; Chow WH; Waldman FM; Moore LE
Clin Cancer Res; 2008 Aug; 14(15):4726-34. PubMed ID: 18676741
[TBL] [Abstract][Full Text] [Related]
14. [Inactivation of the VHL gene in sporadic clear cell renal cancer].
Mikhaĭlenko DS; Kurynin RB; Popov AM; Kariakin OB; Enikeev ME; Aliaev IuG; Nemtsova MV; Zaletaev DV
Mol Biol (Mosk); 2008; 42(1):71-7. PubMed ID: 18389622
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.
van Houwelingen KP; van Dijk BA; Hulsbergen-van de Kaa CA; Schouten LJ; Gorissen HJ; Schalken JA; van den Brandt PA; Oosterwijk E
BMC Cancer; 2005 Jun; 5():57. PubMed ID: 15932632
[TBL] [Abstract][Full Text] [Related]
16. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
[TBL] [Abstract][Full Text] [Related]
18. Carotenoid and vitamin intake, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma.
van Dijk BA; Schouten LJ; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
Cancer Causes Control; 2008 Mar; 19(2):125-34. PubMed ID: 17992578
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Significance of
Kim HS; Kim JH; Jang HJ; Han B; Zang DY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149673
[TBL] [Abstract][Full Text] [Related]
20. The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis.
Yang L; Zhao Z; Zhao S; Chen C; Cong X; Li Z; Ren M
Cell Physiol Biochem; 2016; 40(6):1465-1472. PubMed ID: 27997886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]